Selected research
Industry Research
NAC (Acetylcysteine) Industry Research Report 2026
Market perspective
The global NAC (Acetylcysteine) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for NAC (Acetylcysteine) is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for NAC (Acetylcysteine) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for NAC (Acetylcysteine) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of NAC (Acetylcysteine) include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global NAC (Acetylcysteine) market in revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to NAC (Acetylcysteine).
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
NAC (Acetylcysteine) Market by Company
Manus Aktteva Biopharma
Moehs
Nippon Rika
Pharmazell
Zambon
Shine Star Biological
Xinhanling Biological
Shuguang Biological
Wuhan Grand Hoyo
Huachang Pharmaceutical
Chengyi Pharma
NAC (Acetylcysteine) Segment by Type
Injection
Granule for Oral Solution
Oral Inhalation
Effervescent Tablets
Others
NAC (Acetylcysteine) Segment by Application
Medicine
Health
Others
NAC (Acetylcysteine) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAC (Acetylcysteine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NAC (Acetylcysteine) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAC (Acetylcysteine).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of NAC (Acetylcysteine) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of NAC (Acetylcysteine) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of NAC (Acetylcysteine) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Granule for Oral Solution
- Oral Inhalation
- Effervescent Tablets
- Others
Applications
- Medicine
- Health
- Others
Companies covered
- Manus Aktteva Biopharma
- Moehs
- Nippon Rika
- Pharmazell
- Zambon
- Shine Star Biological
- Xinhanling Biological
- Shuguang Biological
- Wuhan Grand Hoyo
- Huachang Pharmaceutical
- Chengyi Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 NAC (Acetylcysteine) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Injection
- 2.2.3 Granule for Oral Solution
- 2.2.4 Oral Inhalation
- 2.2.5 Effervescent Tablets
- 2.2.6 Others
- 2.3 NAC (Acetylcysteine) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Medicine
- 2.3.3 Health
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global NAC (Acetylcysteine) Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global NAC (Acetylcysteine) Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global NAC (Acetylcysteine) Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global NAC (Acetylcysteine) Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global NAC (Acetylcysteine) Production by Manufacturers (2021-2026)
- 3.2 Global NAC (Acetylcysteine) Production Value by Manufacturers (2021-2026)
- 3.3 Global NAC (Acetylcysteine) Average Price by Manufacturers (2021-2026)
- 3.4 Global NAC (Acetylcysteine) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global NAC (Acetylcysteine) Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global NAC (Acetylcysteine) Manufacturers, Product Type & Application
- 3.7 Global NAC (Acetylcysteine) Manufacturers Established Date
- 3.8 Global NAC (Acetylcysteine) Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Manus Aktteva Biopharma
- 4.1.1 Manus Aktteva Biopharma NAC (Acetylcysteine) Company Information
- 4.1.2 Manus Aktteva Biopharma NAC (Acetylcysteine) Business Overview
- 4.1.3 Manus Aktteva Biopharma NAC (Acetylcysteine) Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Manus Aktteva Biopharma Product Portfolio
- 4.1.5 Manus Aktteva Biopharma Recent Developments
- 4.2 Moehs
- 4.2.1 Moehs NAC (Acetylcysteine) Company Information
- 4.2.2 Moehs NAC (Acetylcysteine) Business Overview
- 4.2.3 Moehs NAC (Acetylcysteine) Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Moehs Product Portfolio
- 4.2.5 Moehs Recent Developments
- 4.3 Nippon Rika
- 4.3.1 Nippon Rika NAC (Acetylcysteine) Company Information
- 4.3.2 Nippon Rika NAC (Acetylcysteine) Business Overview
- 4.3.3 Nippon Rika NAC (Acetylcysteine) Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Nippon Rika Product Portfolio
- 4.3.5 Nippon Rika Recent Developments
- 4.4 Pharmazell
- 4.4.1 Pharmazell NAC (Acetylcysteine) Company Information
- 4.4.2 Pharmazell NAC (Acetylcysteine) Business Overview
- 4.4.3 Pharmazell NAC (Acetylcysteine) Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Pharmazell Product Portfolio
- 4.4.5 Pharmazell Recent Developments
- 4.5 Zambon
- 4.5.1 Zambon NAC (Acetylcysteine) Company Information
- 4.5.2 Zambon NAC (Acetylcysteine) Business Overview
- 4.5.3 Zambon NAC (Acetylcysteine) Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Zambon Product Portfolio
- 4.5.5 Zambon Recent Developments
- 4.6 Shine Star Biological
- 4.6.1 Shine Star Biological NAC (Acetylcysteine) Company Information
- 4.6.2 Shine Star Biological NAC (Acetylcysteine) Business Overview
- 4.6.3 Shine Star Biological NAC (Acetylcysteine) Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Shine Star Biological Product Portfolio
- 4.6.5 Shine Star Biological Recent Developments
- 4.7 Xinhanling Biological
- 4.7.1 Xinhanling Biological NAC (Acetylcysteine) Company Information
- 4.7.2 Xinhanling Biological NAC (Acetylcysteine) Business Overview
- 4.7.3 Xinhanling Biological NAC (Acetylcysteine) Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Xinhanling Biological Product Portfolio
- 4.7.5 Xinhanling Biological Recent Developments
- 4.8 Shuguang Biological
- 4.8.1 Shuguang Biological NAC (Acetylcysteine) Company Information
- 4.8.2 Shuguang Biological NAC (Acetylcysteine) Business Overview
- 4.8.3 Shuguang Biological NAC (Acetylcysteine) Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Shuguang Biological Product Portfolio
- 4.8.5 Shuguang Biological Recent Developments
- 4.9 Wuhan Grand Hoyo
- 4.9.1 Wuhan Grand Hoyo NAC (Acetylcysteine) Company Information
- 4.9.2 Wuhan Grand Hoyo NAC (Acetylcysteine) Business Overview
- 4.9.3 Wuhan Grand Hoyo NAC (Acetylcysteine) Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Wuhan Grand Hoyo Product Portfolio
- 4.9.5 Wuhan Grand Hoyo Recent Developments
- 4.10 Huachang Pharmaceutical
- 4.10.1 Huachang Pharmaceutical NAC (Acetylcysteine) Company Information
- 4.10.2 Huachang Pharmaceutical NAC (Acetylcysteine) Business Overview
- 4.10.3 Huachang Pharmaceutical NAC (Acetylcysteine) Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Huachang Pharmaceutical Product Portfolio
- 4.10.5 Huachang Pharmaceutical Recent Developments
- 4.11 Chengyi Pharma
- 4.11.1 Chengyi Pharma NAC (Acetylcysteine) Company Information
- 4.11.2 Chengyi Pharma NAC (Acetylcysteine) Business Overview
- 4.11.3 Chengyi Pharma NAC (Acetylcysteine) Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Chengyi Pharma Product Portfolio
- 4.11.5 Chengyi Pharma Recent Developments
5 Global NAC (Acetylcysteine) Production by Region
- 5.1 Global NAC (Acetylcysteine) Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global NAC (Acetylcysteine) Production by Region: 2021-2032
- 5.2.1 Global NAC (Acetylcysteine) Production by Region: 2021-2026
- 5.2.2 Global NAC (Acetylcysteine) Production Forecast by Region (2027-2032)
- 5.3 Global NAC (Acetylcysteine) Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global NAC (Acetylcysteine) Production Value by Region: 2021-2032
- 5.4.1 Global NAC (Acetylcysteine) Production Value by Region: 2021-2026
- 5.4.2 Global NAC (Acetylcysteine) Production Value Forecast by Region (2027-2032)
- 5.5 Global NAC (Acetylcysteine) Market Price Analysis by Region (2021-2026)
- 5.6 Global NAC (Acetylcysteine) Production and Value, YOY Growth
- 5.6.1 North America NAC (Acetylcysteine) Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe NAC (Acetylcysteine) Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China NAC (Acetylcysteine) Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan NAC (Acetylcysteine) Production Value Estimates and Forecasts (2021-2032)
6 Global NAC (Acetylcysteine) Consumption by Region
- 6.1 Global NAC (Acetylcysteine) Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global NAC (Acetylcysteine) Consumption by Region (2021-2032)
- 6.2.1 Global NAC (Acetylcysteine) Consumption by Region: 2021-2026
- 6.2.2 Global NAC (Acetylcysteine) Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America NAC (Acetylcysteine) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America NAC (Acetylcysteine) Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe NAC (Acetylcysteine) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe NAC (Acetylcysteine) Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific NAC (Acetylcysteine) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific NAC (Acetylcysteine) Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa NAC (Acetylcysteine) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa NAC (Acetylcysteine) Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global NAC (Acetylcysteine) Production by Type (2021-2032)
- 7.1.1 Global NAC (Acetylcysteine) Production by Type (2021-2032) & (K Tons)
- 7.1.2 Global NAC (Acetylcysteine) Production Market Share by Type (2021-2032)
- 7.2 Global NAC (Acetylcysteine) Production Value by Type (2021-2032)
- 7.2.1 Global NAC (Acetylcysteine) Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global NAC (Acetylcysteine) Production Value Market Share by Type (2021-2032)
- 7.3 Global NAC (Acetylcysteine) Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global NAC (Acetylcysteine) Production by Application (2021-2032)
- 8.1.1 Global NAC (Acetylcysteine) Production by Application (2021-2032) & (K Tons)
- 8.1.2 Global NAC (Acetylcysteine) Production Market Share by Application (2021-2032)
- 8.2 Global NAC (Acetylcysteine) Production Value by Application (2021-2032)
- 8.2.1 Global NAC (Acetylcysteine) Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global NAC (Acetylcysteine) Production Value Market Share by Application (2021-2032)
- 8.3 Global NAC (Acetylcysteine) Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 NAC (Acetylcysteine) Value Chain Analysis
- 9.1.1 NAC (Acetylcysteine) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 NAC (Acetylcysteine) Production Mode & Process
- 9.2 NAC (Acetylcysteine) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 NAC (Acetylcysteine) Distributors
- 9.2.3 NAC (Acetylcysteine) Customers
10 Global NAC (Acetylcysteine) Analyzing Market Dynamics
- 10.1 NAC (Acetylcysteine) Industry Trends
- 10.2 NAC (Acetylcysteine) Industry Drivers
- 10.3 NAC (Acetylcysteine) Industry Opportunities and Challenges
- 10.4 NAC (Acetylcysteine) Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst